Understanding Ketamine's Dissociative Effects (KD Study)

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT04861051
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ketamine — DRUG
    Study participants will receive 0.5mg/kg of ketamine - one single infusion

Study Details

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Key Dates

Start date
Jul 26, 2021
Status verified
Apr 2026
Primary completion
Aug 1, 2028
Completion
Aug 1, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Other: Ketamine
    Study participants will receive 0.5mg/kg of ketamine - one single infusion

Primary Outcome Measure

Number of participants with dissociative events during ketamine infusion as assessed by CADSS (Clinician-Administered Dissociative State Scale) [ Time Frame: up to 1 week ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicinePalo AltoCalifornia94305
Karl Deisseroth, MD, PhD

Find similar trials in Palo Alto, CA

By condition
Epilepsy
By specialty
NeurologyBrain disorders
By research site
Stanford University School of Medicine· Palo Alto, CA

Related Studies